Trust Company of Vermont’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.8K | Buy |
7,200
+1,000
| +16% | +$9.28K | ﹤0.01% | 504 |
|
|
2025
Q1 | $45.4K | Hold |
6,200
| – | – | ﹤0.01% | 534 |
|
|
2024
Q4 | $52.9K | Hold |
6,200
| – | – | ﹤0.01% | 521 |
|
|
2024
Q3 | $53.9K | Hold |
6,200
| – | – | ﹤0.01% | 507 |
|
|
2024
Q2 | $42.4K | Buy |
6,200
+200
| +3% | +$1.37K | ﹤0.01% | 516 |
|
|
2024
Q1 | $54.6K | Hold |
6,000
| – | – | ﹤0.01% | 477 |
|
|
2023
Q4 | $26.8K | Buy |
6,000
+1,000
| +20% | +$4.46K | ﹤0.01% | 513 |
|
|
2023
Q3 | $15.7K | Buy |
5,000
+1,000
| +25% | +$3.14K | ﹤0.01% | 604 |
|
|
2023
Q2 | $20.6K | Hold |
4,000
| – | – | ﹤0.01% | 583 |
|
|
2023
Q1 | $21.1K | Hold |
4,000
| – | – | ﹤0.01% | 595 |
|
|
2022
Q4 | $11.2K | Buy |
+4,000
| New | +$11.2K | ﹤0.01% | 670 |
|